TPG, Lyft, and GeneDX announced deals; Onsemi, meanwhile, ended discussions after offering its target $35.10 per share.

The company's bankruptcy has spotlighted the vulnerability of private consumer genetic testing data.

Three congressmen on the House Committee on Energy and Commerce sent a letter to the genetic testing company 23andMe on ...

The US Justice Department said Thursday it may review a potential sale of 23andMe users’ genetic data for potential national ...

23andMe exploded into the mainstream with its at-home DNA testing kits that gave customers insight into their family ...

Attorneys general from 27 states and the District of Columbia moved to appoint a consumer privacy ombudsman and security ...

On March 23, 2025, 23andMe, along with its affiliates, filed for voluntary Chapter 11 bankruptcy. The company’s decision to file for ...

A U.S. House committee on Tuesday asked 23andMe's co-founder to testify next month as it launched an investigation into the ...

Me’s recent Chapter 11 bankruptcy filing has sparked significant concerns over the privacy and security of genetic data belonging to its ...

Me has filed for bankruptcy as is seeking buyers. Here's what could happen to the company's DNA database, one of the largest ...

Sen. Bill Cassidy is probing 23andMe, which recently filed for bankruptcy protection, to ensure the company does not sell ...